Precigen (PGEN) Asset Writedowns and Impairment (2014 - 2023)

Precigen (PGEN) has 10 years of Asset Writedowns and Impairment data on file, last reported at $445000.0 in Q4 2023.

• On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to $445000.0 in Q4 2023; TTM through Jun 2025 was $445000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $32.9 million, up 7296.63% from the prior year.
• Asset Writedowns and Impairment for Q4 2023 stood at $445000.0, down from $638000.0 in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for PGEN reached as high as $2.8 million in Q4 2019 and fell as low as -$676000.0 in Q4 2021.
• Historically, Asset Writedowns and Impairment has averaged $527916.7 across 5 years, with a median of $446500.0 in 2019.
• Across the five-year window, Asset Writedowns and Impairment surged 1435.16% in 2019 and tumbled 582.86% in 2021, its largest moves.
• Year by year, Asset Writedowns and Impairment stood at $2.8 million in 2019, then plunged by 94.99% to $140000.0 in 2020, then tumbled by 582.86% to -$676000.0 in 2021, then surged by 194.38% to $638000.0 in 2022, then slumped by 30.25% to $445000.0 in 2023.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $445000.0 in Q4 2023, $638000.0 in Q2 2022, and $334000.0 in Q1 2022.